Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PINTA 745 in ESRD Patients With Protein Energy Wasting
NCT01958970Phase 2Completed
- Sponsor
- Pinta Biotherapeutics, Inc.
- Start
- Jan 2014
- Primary completion
- Nov 2015
- Countries
- 1
01
Overview
A Phase 2 trial of PINTA 745 in protein-energy wasting (PEW), sponsored by Pinta Biotherapeutics, Inc.. Started Jan 2014; status: completed.
02
Drugs
PINTA 745
03
Conditions
protein-energy wasting (PEW)
Beyond the preview
Go deeper on NCT01958970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01958970.